Cargando…
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
INTRODUCTION: External beam radiotherapy is a treatment option for clinically localised prostate cancer; however, some 15% of patients will undergo treatment failure within 5 years. The objective was to compare the Cancer of the Prostate Risk Assessment (CAPRA) score (based on the clinical-pathologi...
Autores principales: | Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Salazar, Anibal, Guzman, Eghon, Orrego, Shenda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289617/ https://www.ncbi.nlm.nih.gov/pubmed/32565895 http://dx.doi.org/10.3332/ecancer.2020.1042 |
Ejemplares similares
-
The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2020) -
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2019) -
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone
por: Murray, Nigel P, et al.
Publicado: (2020) -
Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone
por: Murray, Nigel P, et al.
Publicado: (2021) -
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
por: Murray, Nigel P, et al.
Publicado: (2019)